TEVA CANADA LTD (E60PH-22DRUG/012/PH~001)
Contract number E60PH-22DRUG/012/PH
Contract award date
Expiry date
Contract value CAD 2,102,268.17
Contract details
This contract was awarded to:
TEVA CANADA LIMITED
- Business address
-
30 Novopharm CourtToronto, Ontario, M1B2K9Canada
-
Standardized name
-
TEVA CANADA LTD
- Procurement method
- Competitive – Open Bidding
-
Number of employees
-
2500 to 4999 employees
- Language(s)
-
English,French
- Selection criteria
- Lowest Price
Contract duration
Refer to the description above for full details.
Total value of contract
This is the total value of this contract, which includes the initial contract value and the sum of all amendments.
CAD 2,102,268.17
Commodity - GSIN
- N6505 - Drugs and Biologicals
Contact information
Contracting organization
- Organization
-
Public Works and Government Services Canada
Buying organization(s)
Related notices
Amendments made to this contract (2) A total of 2 amendments have been made to this contract. Click to collapse
This is a list of the amendments made to contract
E60PH-22DRUG/012/PH that is awarded to TEVA CANADA LIMITED.
Amendment number
|
Contract value
|
Award date
|
|---|---|---|
| 000 | CAD 2 102 268.17 | 2022/09/09 |
| 002 | CAD 2 102 268.17 | 2022/09/09 |
Tender notices (1) This contract has 1 related tender notices. Click to collapse
|
Title
|
Solicitation Number
|
Publication date
|
Closing date
|
|---|---|---|---|
| Multi-Source Pharmaceuticals | E60PH-22DRUG/A | 2022/07/26 | 2022/08/15 |
Contracts awarded (13) This contract has 13 related award notices. Click to collapse
This is a list of other contracts that were awarded related to solicitation number E60PH-22DRUG/A. Click the link under “More details” to view the contract details.
|
Company name
|
Contract number
|
Amendment date
|
Award date
|
More details |
|---|---|---|---|---|
| Bauschhealth, Canada Inc | E60PH-22DRUG/003/PH | 2023/11/30 | 2022/09/13 | Viewthe details of contract E60PH-22DRUG/003/PH for Bauschhealth, Canada Inc |
| Auro Pharma Inc | E60PH-22DRUG/002/PH | 2023/06/09 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/002/PH for Auro Pharma Inc |
| JAMP Pharma Corporation | E60PH-22DRUG/005/PH | 2023/06/01 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/005/PH for JAMP Pharma Corporation |
| SANDOZ CANADA INC. | E60PH-22DRUG/011/PH | 2023/06/09 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/011/PH for SANDOZ CANADA INC. |
| Natco Pharma (Canada) Inc. | E60PH-22DRUG/007/PH | 2023/06/01 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/007/PH for Natco Pharma (Canada) Inc. |
| Pharmascience Inc. | E60PH-22DRUG/010/PH | 2023/05/31 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/010/PH for Pharmascience Inc. |
| Odan Laboratories Ltd. | E60PH-22DRUG/008/PH | 2023/06/01 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/008/PH for Odan Laboratories Ltd. |
| Marcan Pharmaceuticals Inc. | E60PH-22DRUG/006/PH | 2023/05/31 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/006/PH for Marcan Pharmaceuticals Inc. |
| Teva Canada Limited | E60PH-22DRUG/012/PH | 2023/06/06 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/012/PH for Teva Canada Limited |
| Apotex Inc. | E60PH-22DRUG/001/PH | 2023/06/14 | 2022/09/09 | Viewthe details of contract E60PH-22DRUG/001/PH for Apotex Inc. |
Contract history (28) This contract has 28 related contracts. Click to collapse
This is a list of other contracts that were awarded and their amendments. Click the link under “More details” to view the contract details.
